HIV prevention research: the ecstasy and the agony

The Lancet

Volumn 372, Issue 9654, 2008, Pages 1932-1933

  Cates, Willard ^a   Feldblum, Paul ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CARBOPOL 974P; CARRAGEENAN; CELLULOSE SULFATE; NONOXINOL 9; PRO 2000; SURFACTANT; TENOFOVIR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; VIRUS LOAD;

EID: 57049121807     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61824-3     Document Type: Note

References (22)

1. Horton R., and Das P. Putting prevention at the forefront of HIV/AIDS. Lancet 372 (2008) 421-422
2. Bailey R.C., Moses S., Parker C.B., et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 (2007) 643-656
3. Gray R.H., Kigozi G., Serwadda D., et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369 (2007) 657-666
4. Padian N.S., van der Straten A., Ramjee G., et al., the MIRA Team. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 370 (2007) 251-261
5. Celum C., Wald A., Hughes J., et al., the HPTN 039 Protocol Team. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 2109-2119
6. Buchbinder S.P., Mehrotra D.V., Duerr A., et al., for the the Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 374 (2008) 1881-1893
7. Skoler-Karpoff S., Ramjee G., Ahmed K., et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008) 1977-1987
8. Roddy R.E., Zekeng L., Ryan K.A., Tamoufe U., Weir S.S., and Wong E.L. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 339 (1998) 504-510
9. Van Damme L., Ramjee G., Alary M., et al., behalf of the COL-1492 study group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360 (2002) 971-977
10. Peterson L., Nanda K., Opoku B., et al. SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS ONE 2 (2007) e1312
11. Feldblum P.J., Adeiga A., Bakare R., et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS ONE 3 (2008) e1474
12. Van Damme L., Govinden R., Mirembe F., et al., for the CS Study Group. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 359 (2008) 463-472
13. Halpern V., Ogunsola F., Obunge O., et al. Effectiveness of cellulose sulfate vaginal gel for prevention of HIV infection: results of the phase III trial in Nigeria. PLoS ONE 3 (2008) e3784
14. Geary C.W., Tchupo J.-P., Johnson L., Cheta C., and Nyama T. Respondent perspectives on self-report measures of condom use. AIDS Educ Prev 15 (2003) 499-515
15. Wallace A.R., Teitelbaum A., Wan L., et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception 76 (2007) 53-56
16. Trussell J., and Dominik R. Will microbicide trials yield unbiased estimates of microbicide efficacy?. Contraception 72 (2005) 408-413
17. Cohen M.S., Gay C., Kashuba A.D., Blower S., and Paxton L. Antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med 146 (2007) 591-601
18. Guay L.A., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354 (1999) 795-802
19. Peterson L., Taylor D., Roddy R., et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2 (2007) e27
20. Padian N.S., Buvé A., Balkus J., Serwadda D., and Cates Jr. W. Biomedical intervention to prevent HIV infection: evidence, challenges, and way forward. Lancet 372 (2008) 585-599
21. Cates Jr. W., and Hinman A.R. AIDS and absolutism-the demand for perfection in prevention. N Engl J Med 327 (1992) 492-494
22. Merson M.H., O'Malley J., Serwadda D., and Apisuk C. The history and challenge of HIV prevention. Lancet 372 (2008) 475-488